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During invasion of host cells by Trypanosoma cruzi,
the parasite that causes Chagas disease, the elon-
gated, flagellated trypomastigotes remodel into
oval amastigotes with no external flagellum. The
underlying mechanism of this remodeling and the
fate of the flagellum are obscure. We discovered
that T. cruzi trypomastigotes discard their flagella
via an asymmetric cellular division. The flagellar
proteins liberated become among the earliest para-
site proteins to enter the MHC-I processing pathway
in infected cells. Indeed, paraflagellar rod protein
PAR4-specific CD8+ T cells detect infected host cells
>20 hr earlier than immunodominant trans-sialidase-
specific T cells. Overexpression of PAR4 in T. cruzi
enhanced the subdominant PAR4-specific CD8+
T cell response, resulting in improved control of a
challenge infection. These results provide insights
into previously unappreciated events in intracellular
invasion by T. cruzi and highlight the importance of
T cells that recognize infected host cells early in the
infectious process, in the control of infections.
INTRODUCTION
Chagas disease, caused by the hemoflagellate protozoan para-
site Trypanosoma cruzi has a large and growing worldwide
impact. Globally, it is the leading cause of infectious myocarditis
(Feldman and McNamara, 2000), with millions infected in
endemic areas of the Americas. Although T. cruzi infection in-
duces robust humoral and cellular immune responses that nor-
mally result in the control of the acute infection, the infection is
rarely completely resolved. The deficits in the immune response
that prevent parasitological cure are of significant interest, since
it is the chronic persistence of T. cruzi that ultimately leads to the
clinical disease decades after the initial infection (Zhang and Tar-
leton, 1999).
CD8+ T cells are known to be key players in the control of
T. cruzi infection (Tarleton et al., 1992, 1994), and a significant
proportion of the anti-T. cruzi CD8+ T cells are specific for epi-
topes derived from parasite trans-sialidase family proteins (Mar-Cell Hostin et al., 2006). Trans-sialidases are encoded by a family of
>3,000 highly variable genes that differ between isolates and
are also capable of intraisolate recombination. The trans-siali-
dase-specific CD8+ T cell response, despite being surprisingly
large numerically, is dispensable for normal control of the infec-
tion (Rosenberg et al., 2010). These findings, as well as the enor-
mous potential for epitope variability in the trans-sialidase family,
have created interest in the identification of other, invariant, non-
large gene-family proteins of T. cruzi that could elicit CD8+ T cell
responses to epitopes that are shared among all isolates.
Among the multiple factors that govern the strength of CD8+
T cell response to a particular epitope, the access of the protein
to the host cell cytoplasm (Garg et al., 1997) and the amount of
that protein that reaches the antigen processing machinery
(Wherry et al., 2002) are especially critical. In addition to the
strength, in frequency, of the T cell response, the ability of
T cells to detect and destroy pathogen-infected cells early in
the infection cycle, thus restricting parasite replication potential,
contributes to success in infection control (Yates et al., 2011). In
T. cruzi infection, the movement of parasites from the extracel-
lular space to the cytoplasm of host cells in mammals involves
conversion of the infecting flagellated trypomastigotes to the
morphologically distinct amastigotes that lack an extended fla-
gellum. We hypothesized that the remodeling required for
this conversion would result in the release and subsequent
degradation of parasite proteins that gain access to host cell
class I MHC presentation pathways. Furthermore, increasing
the expression of nonvariant proteins released during this re-
modeling should enhance their immunogenicity and would be
expected to augment immune control of T. cruzi.
In this study, we document that T. cruzi sacrifices its flagellum
during amastigogenesis in host cells shortly after invasion, mak-
ing the released flagellar proteins among the earliest parasite
proteins available for presentation to CD8+ T cells. The flagellum
of trypanosomatids contains a unique network of cytoskeletal
filaments referred to as the paraflagellar rod (PFR) that lies
alongside the axoneme and is involved in motility, flagellar beat
patterns, and possibly tissue attachment (Maga and LeBowitz,
1999). The PFR in T. cruzi is composed of four proteins: PAR1–
4, with PAR4 being the least studied in terms of its biology
and immunogenicity (Luhrs et al., 2003). Here, we show that
PAR4 is the target of T. cruzi-specific CD8+ T cell responses
and that a T. cruzi strain transgenically overexpressing PAR4
(TcPAR4) induced enhanced PAR4-specific CD8+ T cell re-
sponses that provided significantly improved protection fromt & Microbe 16, 439–449, October 8, 2014 ª2014 Elsevier Inc. 439
Figure 1. T. cruzi Sacrifices Its Flagellum
during Intracellular Amastigogenesis
(A–C) Fluorescent (top panels) and DIC overlay
(bottom panels) showing T. cruzi flagellum in the
extracellular trypomastigote stage (A) and sepa-
rated from the newly formed amastigote (6–9 hr
postinfection) in the host cell cytoplasm ([B] and
[C]). The white and yellow arrows, respectively,
indicate the basal body and DNA associated with
the flagellum.
(D) An intact flagellum is not evident in an infected
host cell with a single amastigote 9–12 hr post-
infection, but flagellar origin PAR4 (HA-tagged)
‘‘particles’’ appear in the host cell cytoplasm.
Anti-PAR4 ([A]–[C]) or PAR4-HA (D) used to track
T. cruzi PAR4. 40,6-diamidino-2-phenylindole
(DAPI) ([A]–[C]) or propidium iodide (PI) (D) stained
DNA, and anti-centrin marked the basal body
([A]–[C]). CN indicates host cell nucleus. Scale bar,
10 mm. See also Figures S1 and S2.
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other flagellar proteins as potential vaccines for T. cruzi and other
intracellular flagellates and support the overexpression of sub-
dominant T cell targets as a strategy for improving live attenu-
ated vaccines.
RESULTS
T. cruzi Sacrifices Its Flagellum during Amastigogenesis
Though one of the most conspicuous changes to T. cruzi during
intracellular amastigogenesis is the conversion of the extensively
flagellated trypomastigote to an amastigote with only a remnant
of a flagellum, little is known concerning the underlying mecha-
nism by which this happens or the fate of the flagellum during
this process. To investigate these questions, we first visualized
the flagellum of T. cruzi in the trypomastigote stage by expres-
sion of a tagged version of PAR4 in T. cruzi (PAR4-tdTomato/
PAR4-HA) or using anti-PAR4 antibody. PAR4 localized only to
the flagellar compartment of the trypomastigotes (Figure 1A) un-
less the carboxy-terminal flagellar localization signal was trun-
cated (tr.PAR4) (Figures S1 and S2 available online), consistent
with the distribution of the PAR4 ortholog in T. brucei (Bastin
et al., 1999). Upon invasion of host cells, the flagellum appears
disassociated from the developing amastigote but retains a
connection to both a basal body and DNA (presumably kineto-
plast DNA) (Figures 1B and 1C), suggesting a duplication of
these two organelles prior to release of the flagellum. Further
analysis of this transformation both inside host cells (Figure S3)
and axenically (Figure 2) demonstrates that during amastigogen-
esis, trypomastigotes release their flagella via an asymmetrical
division resulting in two daughter cells, one with a barely notice-
able flagellum devoid of the PFR (Bastin et al., 1996), that
matches the classical description of a newly formed amastigote
(Andrews et al., 1987) and a second daughter with a smaller cell
body and an extensive flagellum.
During this process of asymmetric division, T. cruzi trypomas-
tigotes first transform into biflagellated intermediates with two ki-
netoplasts and two flagella (Figures 2A and S4I), but only a single
nucleus, before cytokinesis into the two morphologically distinct440 Cell Host & Microbe 16, 439–449, October 8, 2014 ª2014 Elseviedaughter cells. The nucleated daughter cell (1K1N) has a func-
tional kinetoplast identifiable by kinetoplast-associated protein
and mitotracker staining (Figures 2B and S4A) and a short flagel-
lum (Figures 1C, 1D, and S4A). The nucleus inherited by the first
generation 1K1N daughter amastigote from the parent trypo-
mastigote has not undergone replication during this process,
as indicated by the absence of BrdU incorporation during this
early host cell invasion period (Figure S4E). These fully compe-
tent daughter amastigotes presumably progress further in their
intracellular development over 4 to 5 days with discernible
morphological changes and replication (with nuclear BRdU
incorporation; Figures 2D, S3, S4C, and S4F).
The 1K0N daughter cell possesses an intact kinetoplast (Fig-
ures 2C and S4B) and a flagellum with associated basal body
(Figures 1B and 1C) and is initially surrounded by a plasma
membrane, as indicated by detection of the plasma membrane
PI-PLC (Figure 2G). However the only discernable DNA in the
1K0N daughter is associated with the kinetoplast (Figure 2C).
In axenic culture, these 1K0N daughter cells showed a clear
loss of integrity over time, with a reduction in cell volume (Fig-
ure 2E), loss of kinetoplast (Figures 2E, 2F, and S4D), and
flagellar motility. The progressive conversion of the population
of trypomastigotes into biflagellated intermediates and then
1K1N and 1K0N daughter cells can bemonitored axenically (Fig-
ures S4G and S4H) andwithin host cells (Figure S4I) and is nearly
complete by 8 hr. Evidence for the eventual disintegration of the
flagellum in the infected host cell includes the failure to detect
intact 1K0N daughters after 9–12 hr postinfection and the obser-
vation of minute HA-tagged (PAR4) ‘‘particles’’ in the cytosol of
TcPAR4-infected macrophages (Figure 1D).
Thus, upon host cell infection, T. cruzi trypomastigotes un-
dergo cytokinesis without nuclear division as a means of dis-
charging the large but now unnecessary flagellum into the host
cell cytoplasm where it then is degraded.
T. cruzi Flagellar Component PAR4 Is Recognized by
CD8+ T Cells
One critical factor in the generation of CD8+ T cell responses
against T. cruzi proteins is the access of these proteins to ther Inc.
Figure 2. Asymmetric Division during
T. cruzi Amastigogenesis Yields 1K1N and
1K0N Daughter Cells
(A–C) Fluorescent (top panels) and DIC imaging
(bottom panels) showing the major stages in
T. cruzi amastigogenesis induced by axenic con-
version. In 2–4 hr, T. cruzi trypomastigotes con-
verts to biflagellated intermediate stage (A) that in
4–9 hr gives rise to morphologically dissimilar
1K1N daughter cells with intact kinetoplast and
nucleus (B) and 1K0N daughter cells with kineto-
plast but no distinct nucleus (C).
(D–F) Over the next 9–16 hr, the nucleus and kinet-
oplast of the 1K1N daughter remains intact (D), but
the kinetoplast and cell body of the 1K0N daughter
progressively loses its integrity ([E] and [F]).
(G) The 1K0N daughter is enclosed by a plasma
membrane (6 hr postinduction of amastigogenesis,
[G]).T.cruziDNA ([A]–[G]), kinetoplast ([A]–[F]), PAR4
(G), or plasma membrane (G) were marked using
DAPI, anti-KAP3, -PAR4,or –TcPiPLC, respectively.
Scale bar, 5 mm. See also Figures S3 and S4.
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decomposition of the T. cruzi flagellum in host cells suggest
that flagellar proteins from T. cruzi would be some of the first
pathogen proteins available to host cell proteasome machinery
for antigen processing in T. cruzi-infected host cells. Like other
better-studied flagellar components, PAR4 is one of the more
abundant proteins in T. cruzi trypomastigotes (Atwood et al.,
2005) but has not previously been examined as a possible target
of host immune responses. A distinct CD8+ T cell response to
PAR4 was observed in T. cruzi (wild-type Brazil strain, Tcwt) in-
fected mice (Figures 3A and 3B). An H2b MHC-l restricted
epitope appeared to be present in the amino terminal region of
PAR4 (PAR4(N)) (Figure 3C), with PAR4(N)-specific, functional
CD8+ T cells being generated in T. cruzi-infected C57Bl/6J
mice (Figure 3D). Although clearly detectable, the PAR4-specific
response is less potent than the highly dominant T. cruzi trans-
sialidase-derived, TSKb20 epitope-specific response (Martin
et al., 2006). Thus, proteins in the T. cruzi flagellum released dur-
ing amastigogenesis are processed and presented on MHC-I.
Overexpression of PAR4 in T. cruzi Enhances
PAR4-Specific CD8+ T Cell Responses during Infection
Although PAR4 is relatively abundant in T. cruzi trypomastigotes
and elicits a CD8+ T cell response, we hypothesized that an
increased expression of this protein would further promote
its relative immunogenicity. T. cruzi overexpressing its native
PAR4 (TcPAR4) protein were generated by single gene transgen-
esis and were selected under strong drug pressure to achieve a
2-fold increase in PAR4 expression (Figure 4A). TcPAR4 infec-
tion induced a significantly stronger PAR4-specific CD8+ T cell
response compared to Tcwt infection, although still not at the
level of the TSKb20-specific response (Figure 4B). Flagellar
localization was critical to the enhanced PAR4-specific re-
sponses as T. cruzi overexpressing a truncated version of
PAR4 lacking the flagellar localization signals (Tctr.PAR4)
induced a comparable PAR4-specific CD8+ T cell response as
Tcwt (Figure S5). Further, TcPAR4 infection also elicited greater
in vitro (Figure 4C) and in vivo (Figure 4D) target cell lysis
compared to infection with Tcwt. These results confirm that an-Cell Hostigen abundance impacts the immunogenicity of proteins, even
already abundant ones, in T. cruzi.
Based on the SYFPEITHI algorithm (Rammensee et al., 1999),
we identified several potential CD8+ T cell epitopes from
PAR4(N) for the H-2b haplotype and synthesized eight of these
to test as possible CD8+ T cell targets. Two PAR4-derived
H2Db haplotype-restricted epitopes: DSLLNEVSL (PAR4(3))
and KALSDEMEEM (PAR4(5)) were recognized by T cells from
T. cruzi-infected C57BL/6 mice, as reflected in both IFN-g
production (Figure 5A and 5B) and in vivo cytolytic assays
(Figure 5C). In agreement with our earlier observation, overex-
pression of PAR4 induced enhanced PAR4(3)- and PAR4(5)-spe-
cific CD8+ T cell responses (Figure 5B).
PAR4Transgenesis Induces ImprovedControl of T. cruzi
Infection
Given the heightened PAR4-specific CD8+ T cell response
observed in infections with the PAR4-overexpressing TcPAR4,
we hypothesized that immunization with TcPAR4 would provide
a more potent and also cross-strain protective response against
wild-type (WT) T. cruzi challenge relative to Tcwt. To test this hy-
pothesis, we infected mice with TcPAR4 or Tcwt parasites and
then drug-cured the infection using benznidazole to simulate
vaccination (Bustamante et al., 2008). These mice were then
challenged in each footpad with tdTomato fluorescent protein-
expressing T. cruzi (CL strain) (Canavaci et al., 2010), and para-
site load at the site of infection was monitored by in vivo imaging
(Collins et al., 2011) and by PCR for detection of parasite DNA in
tissues (Figure 6A). By day 4 postinfection, TcPAR4-immunized
mice displayed a significant decline in parasite numbers, as re-
flected in fluorescence signal, compared to Tcwt vaccinated or
the control nonvaccinated (primi-infection) mice (Figures 6B
and 6C). TcPAR4-immunized mice also exhibited significantly
reduced parasite loads in skeletal muscle tissue at day 30 post-
challenge, as compared to Tcwt-immunized or nonimmunized
mice (Figure 6D). Vaccination of naive mice with PAR4(3) peptide
also enhanced protection to challenge infection relative to
TSKb20 peptide vaccination (Figure S6). Thus, immunization
with PAR4-overexpressing parasites stimulates a more effectivet & Microbe 16, 439–449, October 8, 2014 ª2014 Elsevier Inc. 441
Figure 3. T. cruzi PAR4 Induces CD8+ T Cell Response in T. cruzi-Infected Mice
(A) Representative wells of IFN-g ELISPOT assay with splenocytes from naive or Tcwt-infected (30 dpi) mice restimulated with rPAR4, rOVA, or PMA/ionomycin
for 18 hr. Bar graph indicates the average number of spots per well for each group from an experiment with three mice/group.
(B) Intracellular IFN-g staining of splenocytes from naive or Tcwt-infected (180 dpi) mice restimulated with rPAR4, rOva, or rOva-TSKb20 for 16 hr. The bar graph
summarizes data from an experiment with three mice/group.
(C) Intracellular IFN-g staining of splenocytes from naive or Tcwt-infected (48 dpi) mice, cocultured for 16 hr with MC-PAR4(N), MC-PAR4(M), MC-PAR4(C),
MC-Ova, or MC-Ova-TSKb20 cells.
(legend continued on next page)
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Figure 4. Overexpression of PAR4 in T. cruzi Enhance the Generation of PAR4-Specific CD8+ T Cells
(A) Relative expression levels of PAR4 in Tcwt and TcPAR4 trypomastigote stage (lysate), as determined by ELISA using serial dilutions of anti-PAR4 immune sera.
(B) Intracellular IFN-g staining of splenocytes derived from Tcwt- or TcPAR4-infected (120 dpi) mice, restimulated with rPAR4(N), rOva, or rOva-TSKb20 for 16 hr.
Histograms are gated on CD8+ CD44+ lymphocytes, with the inset numbers indicating the percentage of IFN-g-producing CD8+ T cells. The bar graph sum-
marizes data from an experiment with three mice/group.
(C) Cytolytic activity of splenocytes from TcPAR4- or Tcwt-infected mice (96 dpi) against MC-PAR4(N) or MC-Ova target cells at different effector-target ratios.
(D) Representative histograms comparing specific killing of CellTrace Violet (CTV)-stained MC-PAR4(N) (CTVhi)/ MC-OVA (CTVlo) target cells inoculated into and
recovered 18 hr later from the peritoneal cavity of naive, Tcwt-, or TcPAR4-infected (300 dpi) mice. The inset numbers represent the relative proportions of
recovered MC-PAR4(N) compared to MC-OVA. The bar graph shows the relative in vivo specific lysis of MC-PAR4(N) in Tcwt- or TcPAR4-infected mice. Data
represents an experiment with threemice/group. All data representative of at least three similar experiments with the bar graphs presenting data asmean ± SEM.
* or n.s indicate pG 0.05 or p > 0.05, respectively, as determined by Student’s t test. See also Figure S5.
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WT T. cruzi.
Rapid Detection of T. cruzi Infection by PAR4-Specific
CD8+ T Cells
T. cruzi infection induces very robust CD8+ cell responses
directed at epitopes in highly immunodominant trans-sialidase
family of proteins, with upward of 30% of the entire mouse
CD8+ T cell compartment being specific for these epitopes at
the peak of the response (Martin et al., 2006). Therefore it was
somewhat surprising that a relatively modest increase in
T. cruzi-specific CD8+ T cells provoked by the overexpression
of PAR4 would impact the course of a challenge infection as
observed here. Since T. cruzi sacrifices its flagellum within a
few hours of host cell invasion, we hypothesized that T. cruzi-in-
fected cells may be detected by PAR4-specific CD8+ T cells rela-
tively quickly as well. To test this hypothesis, murine fibroblasts
infected with T. cruzi for various lengths of time were cocultured
with PAR4(3)- or TSKb20-primed CD8+ T cells and monitored for(D) Intracellular staining for IFN-g in splenocytes from naive or Tcwt-infected (90
summarizes data from an experiment with three mice/group. All histograms ar
percentage of IFN-g-producing CD8+ T cells. All data representative of two to four
or n.s indicate p% 0.01, p% 0.05, or p > 0.05, respectively, as determined by S
Cell Hosrecognition of their respective epitopes. Whereas PAR4(3)+CD8+
T cells recognized host cells infected with T. cruzi within the first
few hours postinfection, T cells specific for the immunodominant
TSKb20 epitope did not recognize T. cruzi-infected host cells un-
til >24 hr postinfection (Figures 7A and 7B).
To control for possible differences in T cell populations and
variable epitope affinity for MHC, we engineered T. cruzi to ex-
press the model antigen ovalbumin (OVA) as a secreted protein
(Tc-ova) or linked to PAR4 (Tc-ova-PAR4) as well as a version
of OVA in which the SIINFEKL epitope had been replaced with
the T. cruzi TSKb20 epitope (TcPAR4-ovaTSKb20) and assessed
the timing of presentation of the respective epitopes in infected
host cells. In agreement with the results of recognition of the
endogenous trans-sialidase- and PAR4-specific T cells, the
OVA SIINFEKL epitope was detectable within hours of host cell
infection by Tc-ova-PAR4 parasites, while presentation of the
secreted OVA took >1 day (Figure 7C). Likewise, TSKb20-spe-
cific T cells recognized host cells within hours when the
TSKb20 epitope was physically linked to PAR4 (Figure 7D).dpi) mice restimulated with rPAR4(N), rOva, or rOva-TSKb20. The bar graph
e gated on CD8+ CD44+ lymphocytes, with the inset numbers indicating the
similar experiments, with the bar graphs presenting data as mean ± SEM. **, *,
tudent’s t test.
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Figure 5. Target Epitope Identification in PAR4-Specific CD8+ T Cells
(A) Representative wells of IFN-gELISPOT assay, where splenocytes from naive or Tcwt-infected (30 dpi) mice were restimulated for 18 hr with the PAR4 peptides
PAR4(3) or PAR4(5). T. cruzi trans-sialidase-derived TSKb20, chicken ovalbumin-derived SIINFEKL peptides, or PMA/ionomycin served as controls. Bar graph
indicates the average spots per well (±SEM) for each group from a representative of three trials with three mice/group. ** indicates p % 0.01 comparing the
indicated groups to SIINFEKL control by Student’s t test.
(B) Representative intracellular IFN-g staining of splenocytes derived from naive, Tcwt-, or TcPAR4-infected (30 dpi) mice restimulated with PAR4(3), PAR4(5),
TSKb20, or SIINFEKL for 5 hr. Histograms are gated on CD8+ CD44+ lymphocytes, with the inset numbers indicating the percentage of IFN-g-producing CD8+
T cells. The bar graph summarizes data from an experiment with three mice/group.
(C) Representative histograms comparing specific killing of PAR4(3) or PAR4(5) (CFSEhi)/ SIINFEKL (CFSElo) peptide pulsed target splenocytes inoculated into
and recovered 18 hr later from naive, Tcwt-, or TcPAR4-infected (300 dpi) mice. The inset numbers represent the percentage of PAR4(3) or PAR4(5) pulsed over
total donor splenocytes recovered. Data represent an experiment with three mice/group. ** or * indicates p% 0.01 or% 0.05, respectively, by Student’s t test. All
data are representative of at least three separate trials.
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Figure 6. TcPAR4 Immunization Enhances Resistance to a T. cruzi Challenge
(A) Schematic showing the methodology of infection (i.p.), cure, challenge (in the superficial subcutaneous tissue of each footpad), and assessment of protection
in TcPAR4- or Tcwt-infected mice.
(B) Representative image from day 4 postchallenge showing the acute control of T. cruzi at the site of infection in naive (primi-challenge) and Tcwt- or TcPAR4-
vaccinatedmice. The parasite load in foot pad, represented by the fluorescent signal of T. cruzi expressing tdTomato (TctdTom), is determined by in vivo imaging.
(C) The control of TctdTom challenge based onmean fluorescent signal of all feet in primi-challenged, Tcwt-, or TcPAR4-immunizedmice at indicated time points.
Data are from an experiment with three mice/group, which is representative of three separate trials.
(D) T. cruziDNA in skeletal muscle tissue of C57BL/6mice immunized with Tcwt or TcPAR4 and challenged with TctdTom as determined by quantitative real-time
PCR, 30 days post challenge. Horizontal bars represent the mean. Unimmunized (primi-infection) or naive mice served as controls. The dotted line represents the
threshold of detection for the assay. Data represented as mean ± SEM from one of two separate experiments with three to six mice/group. ** or * indicates p%
0.01 or% 0.05, respectively, by Student’s t test. See also Figure S6.
Cell Host & Microbe
T. cruzi Flagellar Proteins Are Early T Cell TargetsThus, the ability of PAR4-specific T cells to detect parasite infec-
tion earlier in the infection cycle may be integral to the more
potent effector activity of these cells relative to the abundant
trans-sialidase-specific T cells.
DISCUSSION
Though the life history of T. cruzi has been systematically eluci-
dated over more than 100 years (Brener, 1973; de Souza, 1984;
Tyler and Engman, 2001), some aspects of it still remain a mys-
tery. One such intriguing feature is the cell biology of intracellular
amastigogenesis, where the elongated, flagellated trypomasti-
gotes remodel into oval amastigotes with no external flagellum.
The T. cruzi ubiquitin-proteasome system has been implicated
in this morphogenesis as being responsible for recycling of
now unneeded trypomastigote structures (Gonza´lez et al.,
1996). However, some key structural proteins have remained un-
accounted for in this process. Notably absent among parasite
proteasome targets during amastigogenesis are components
of T. cruzi paraflagellar rod proteins (de Diego et al., 2001), sug-
gesting an alternate mechanism of dealing with the flagella dur-
ing remodeling. This, along with the observation of CD8+ T cells
specific to flagellar structural proteins in T. cruzi infection (Egui
et al., 2012; Michailowsky et al., 2003; Wrightsman et al., 2002)
led us to hypothesize that the T. cruzi flagellum is ‘‘lost’’ into
the host cell cytosol during amastigogenesis. In this study, we
make the observation of the release of the detached T. cruzi fla-Cell Hosgellum into the cytosol of the host cell during amastigogenesis as
a product of an asymmetric division of T. cruzi.
The transition of trypomastigote to amastigote in T. cruzi takes
place without nuclear division and progresses through an inter-
mediate stage (2K1N) with duplicate flagella, basal body, and
kinetoplast, but only a single nucleus. Cytokinesis then gener-
ates a daughter cell (1K1N) with a short flagellum and a second
daughter (1K0N) with a long flagellum and associated basal body
and kinetoplast, but with no evidence of a nucleus. Based upon
previous studies documenting the presence of amastigotes-like
forms within the LAMP+ lysosomal vacuole (Nagajyothi et al.,
2011), it is likely that this early division process is also taking
place within the vacuole, and the two daughters are then
released into the cytoplasm upon dissolution of the vacuolar
membrane (Figure S7). An analogous asymmetric division pro-
cess resulting in long flagellum and short flagellum daughters
is also observed in T. brucei (Sharma et al., 2008; Van Den Ab-
beele et al., 1999). During stage transition in T. brucei procyclics,
the resultant short-flagellated daughter epimastigote continues
through the cell division, while the longer flagellated daughter
epimastigote does not and appears to die (Sharma et al., 2008,
2009; Van Den Abbeele et al., 1999). In the tsetse fly salivary
glands, asymmetric division results in the production of progeny
with distinct flagella, including trypomastigotes preadapted for
infection of mammals (Rotureau et al., 2012). In T. cruzi, the
IK1N daughter presumably spawns the amastigotes that will
eventually fill the host cell, while the 1K0N daughter appears tot & Microbe 16, 439–449, October 8, 2014 ª2014 Elsevier Inc. 445
Figure 7. Rapid Detection of T. cruzi-Infected Cells by PAR4-Specific CD8+ T Cells
(A and B) Representative flow plots (A) and line graph (B) showing the timing of IFN-g response of TSKb20- or PAR4- specific splenic CD8+ T cells restimulated
with murine fibroblasts infected with T. cruzi for the indicated lengths of time. Restimulation with the corresponding peptide epitopes served as controls. All
histograms are gated on CD8+ CD44+ lymphocytes, with the inset numbers indicating the percentage of IFN-g-producing cells. SIINFEKL-specific CD8+ T cells
served as controls.
(C)Timing of IFN-g response in OVA specific CD8+ lymphocytes derived from Lm-ova-infected mice coincubated with murine fibroblasts infected with Tcwt,
Tc-ova, or Tc-ova-PAR4 for the indicated lengths of time.
(D) Timing of IFN-g response in OVA/TSKb20/PAR4(3)-specific CD8+ splenic lymphocytes coincubated with murine fibroblasts infected with Tcwt or TcPAR4-
ovaTSKb20 for the indicated lengths of time. The line graphs present data as mean ± SEM from one of three separate experiments. See also Figure S7.
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retain their flagellum and basal body-kinetoplast complex,
have also been reported in T. brucei (Robinson et al., 1995). In
T. cruzi, the intact flagella of the 1K0N daughter, initially evident
in host cells 2–6 hr postinfection, were undetectable by 12 hr
postinfection; however, HA-tagged (PAR4) particles are visible
soon thereafter. These observations, in addition to providing crit-
ical insights into the biology of T. cruzi, also shed light on the hith-
erto unclear mechanism by which CD8+ T cell responses could
be generated against the unique structural components in
T. cruzi (Miller et al., 1996; Wrightsman et al., 1995, 2002) or
Leishmania spp (Maga et al., 1999; Saravia et al., 2005) flagella
that are absent from these pathogens’ predominant intracellular
stages (Portman and Gull, 2010).
CD8+ T cells are critical to the adaptive immune control of
most intracellular pathogens owing to their ability to produce a
variety of cytokines and to directly target infected host cells for
destruction. In its cytoplasmic niche, T. cruzi releases various
proteins that are processed and presented on class I MHC
molecules (Garg et al., 1997) and may be detected by specific
CD8+ T cells possessing cognate T cell receptors. However, un-
like the genetically simpler viral or bacterial model pathogens,
protozoans, including T. cruzi, potentially elicit CD8+ T cell re-
sponses against a large number of epitopes, spanning multiple
proteins (Doolan et al., 2003; Frickel et al., 2008; Martin et al.,
2006). These responses also appear in a focused, reproducible
hierarchy in which T cell clones of certain epitope specificities
are represented in greater quantities (dominant) than others
(subdominant)—in a phenomenon termed immunodominance
(Yewdell and Bennink, 1999). Given the complexity of the
T. cruzi genome, with hugely expanded sets of variant gene fam-
ilies encoding various surface-expressed and secreted proteins
(El-Sayed et al., 2005), multiple clones of CD8+ T cells form446 Cell Host & Microbe 16, 439–449, October 8, 2014 ª2014 Elseviethe immunodominance hierarchy, led by those specific to the
trans-sialidase family of proteins (Martin et al., 2006; Rosenberg
et al., 2010). Trans-sialidases are part of an enormous gene fam-
ily in T. cruzi, encoded by >3,000 genes (data not shown) and are
also the targets of the majority of T. cruzi-specific CD8+ T cells
in mice, with the responses to other proteins appearing sig-
nificantly subdominant. Though T. cruzi trans-sialidases have
been used as vaccine candidates (Costa et al., 1998; Fontanella
et al., 2008), their diversity and strain-variant nature (Martin et al.,
2006) make them unreliable targets for immunization against
T. cruzi. For this reason, we have focused on the identification
of other subdominant, strain-invariant epitopes from non-large
gene-family proteins as potential vaccine candidates.
A number of studies in viral models have reported a lack of cor-
relation between pathogen control and the general magnitude or
breadth of T cell responses (Addo et al., 2003; Betts et al., 2001).
In contrast, the timing of expression of an epitope by a pathogen
can frequently be linked to the efficiency of T cell responses and
to correlate with protection (Adnan et al., 2006; Yates et al.,
2011). Hence, it is logical that even though strong, immunodomi-
nant CD8+ T cell responses are generated during T. cruzi infec-
tion, the relatively delayed expression on infected host cells of
epitopes recognized by these T cells maymake these responses
less effective and allow for parasite persistence, despite the
strength of this response.
The shedding of the trypomastigote flagellum soon after host
cell entry places epitopes in flagellar proteins among the first sig-
nals identifying T. cruzi-infected cells to host T cells. Further, the
earlier and progressively better control of a T. cruzi challenge
infection in mice with enhanced numbers of PAR4-specific
CD8+ T cells suggests that this ability to recognize infected cells
earlier in the infection cycle is highly beneficial in terms of infec-
tion control.r Inc.
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peptides, a number of other characteristics make proteins in
the T. cruzi flagellum particularly attractive as immunological tar-
gets. These are among the most abundant proteins in the para-
site, are encoded by single genes, and appear largely invariant
among T. cruzi strains. On the negative side, the flagellar pro-
teins may only be present in the host cells ephemerally, although
PAR4-specific T cells recognize infected host cells until at least
48 hr postinfection (Figure 7). However, since production of try-
pomastigotes and reinvasion of new host cells is occurring
continuously during infection, flagellar proteins are available to
prime and boost T cell responses and to serve as targets for
CD8+ T cells throughout the infection.
Given the apparent negative consequences to T. cruzi of
shedding the flagellum upon entering host cells (i.e., providing
early notification to the immune system that the host cell is in-
fected), it is surprising that this route of disposal has survived
natural selection. Possibly, this is the best option for jettisoning
such a large and complex structure that might be difficult for
the parasite to efficiently resorb and otherwise recycle. Also,
unlike flagella in mammalian or algal cells, the flagellum in
T. cruzi trypomastigotes is attached to the cell body along
most its length. Adsorption of such a structure may be more
disruptive than asymmetric division. Notably, the T cell re-
sponses induced by PAR4 are subordinate in terms of fre-
quency to trans-sialidase-specific responses. Perhaps this is
one way that the massive ts family of proteins serves to
generate immune evasion, by deflecting the attention of the
dominant T cell responses away from highly conserved proteins
exposed early in the infection process and toward a set of
related epitopes that are capable of constant change and are
variable among isolates.
Conserved and abundant flagellar proteins, particularly ones
like PAR4 that lack homologs in mammals, should be further
investigated as potential vaccine targets for flagellated intracel-
lular pathogens like Leishmania spp. and T. cruzi. We have
explored this possibility with the intention of engineering attenu-
ated strains of T. cruzi to be more immunogenic and immune
protective. Such lines have promise as animal vaccines to
reduce infection in companion animals and thus transmission
to humans (Cohen andGu¨rtler, 2001). But these flagellar proteins
may also have potential as conventional vaccines. Establishing a
robust T cell response to these conserved proteins before the
exposure to ts epitopes might short-circuit this potential evasion
mechanism and result in much enhanced parasite control. The
approach of letting the life history of a pathogen instruct on
what the immune system should be responding to, rather than
observing what it naturally responds to—perhaps misdirected
to—in the course of infection might indeed be useful in vaccine
development for other complex pathogens with vast numbers
of potential vaccine targets.
EXPERIMENTAL PROCEDURES
Mice, Parasites, and Infections
Female C57BL/6 mice were purchased from The Jackson Laboratory or bred
and maintained in our animal facility under specific pathogen-free conditions.
T. cruzi epimastigotes (Brazil strain) were transfected as described previously
(Garg et al., 1997) with pTREX plasmid (Lorenzi et al., 2003) containing the
coding sequence of full length (1,743 bp) or truncated (1,693 bp) T. cruziCell Hosparaflagellar rod protein 4 (PAR4) gene (TriTrypDB accession number
TcCLB.510353.30), with or without fusion to an upstream td-Tomato gene or
influenza haemagglutinin (HA)-tag, to generate transgenic T. cruzi: TcPAR4.
Unless otherwise indicated, all infections were initiated by inoculating vero
cell culture passaged trypomastigote stage T. cruzi, intraperitoneally (i.p.)
(104 parasites) or subcutaneously in the foot pad (104 parasites). All animal pro-
tocols were approved by the University of Georgia Institutional Animal Care
and Use Committee.
Microscopy
Immunofluorescence microscopy was performed to determine presence of
the PAR4 or tr.PAR4 in epimastigote, trypomastigote, and intracellular and
extracellular amastigote stages of T. cruzi, modifying the protocol described
previously (Agrawal et al., 2009) using TcPAR4, TctdTom (T. cruzi (CL strain)
expressing the tdTomato protein (Canavaci et al., 2010), or Tcwt strains to
infect Vero or human foreskin fibroblast cells. Extracellular amastigogensis
was achieved by axenic conversion as described in detail before (Tomlinson
et al., 1995). Briefly, T. cruzi trypomastigotes were incubated in RPMI media
with 10% fetal calf serum (pH 5.0) at 37C/5%CO2 to induce their conversion
into amastigotes. The initial, intermediate, and terminal morphological stages
in amastigogenesis were observed by fluorescence microscopy and quanti-
fied by sampling at various time points during this process. Anti-PAR4 poly-
clonal serum from infected mice, td-Tomato, or anti-HA (Roche) antibodies
were used to track PAR4 or tr.PAR4. Propidium Iodide or DAPI indicated
DNA and anti-centrin (Chlamydomonas reinhardtii) (Millipore) distinguished
T. cruzi basal body. T. cruzi plasma membrane localizing phosphatidyl inositol
phospholipase C (anti-TcPiPLC, a gift from Dr. Roberto Docampo) or filipin
(binding to cholesterol) were used to mark the parasite surface. Antibody to
the kinetoplast-associated protein (KAP)3 (anti-KAP3, a gift from Dr. Stenio
Fragoso) marked the kinetoplast and MitoTracker Red (Invitrogen) that would
accumulate only in active mitochondria delineated a functional kinetoplast.
The presence of active DNA replication that is associated with nuclear division
in the host cell or T. cruzi was determined by addition of BrdU (BD Biosci-
ences). First and subsequent generations of amastigotes were observed by
paraformaldehyde fixation of infected host cells before 12 hr or after 24 hr of
infection, respectively. Images were acquired with an Applied Precision Delta
Vision microscope and were deconvolved and adjusted for contrast using its
Softworx software.
In Vivo Cytotoxicity Assay
Equal numbers of MC-PAR4(N) or MC-Ova were labeled with different con-
centrations of CellTrace Violet (CTV) (Invitrogen) to produce CTV hi MC-
PAR4(N) and CTV lo MC-Ova. Equal numbers of either were then transferred
i.p. into recipients and, after 18 hr, reisolated by peritoneal lavage to detect
CTV-stained cells by flow cytometry. Similarly, spleen cells from naive mice
incubated for 1 hr at 37C with 10 mM PAR4 (3), PAR4(5), or SIINFEKL pep-
tides were labeled with different concentrations of CFSE (Molecular Probes)
as described before (Martin et al., 2006) to produce CFSE-high and -low pop-
ulations. Equal numbers of CFSE-labeled cells were transferred intravenously
into recipients, and after 18 hr, splenocytes were isolated, and CFSE-labeled
cells were detected by flow cytometry. Percentage of specific lysis was deter-
mined in either case using the following equation: 1  [(% CTV or CFSElo
naive/% CTV or CFSEhi naive)/(% CTV or CFSElo infected/CTV or CFSEhi in-
fected)] 3 100%.
Assessing Protection
The acute control of T. cruzi challenge was determined as described previ-
ously (Collins et al., 2011). A total of 2 3 105 TctdTom parasites were subcu-
taneously inoculated into both footpads of naive mice, or mice drug-cured
(Bustamante et al., 2008) from TcPAR4 or Tcwt infections (104 i.p.), 30 days af-
ter the end of drug treatment. Mouse feet were imaged every day using the
Maestro 2 in vivo imaging system (Caliper Life Sciences) with the green set
of filters (acquisition settings: 560 to 750 in 10-nm steps; exposure time of
88.18 ms and 23 2 binning) for the indicated time period. The total fluorescent
signal was quantified and the values represented as photons/cm2/second.
Skeletal muscle tissue from challenged mice was analyzed at 30 dpi by real-
time PCR for the presence of T. cruzi (DNA), as described before (Cummings
and Tarleton, 2003).t & Microbe 16, 439–449, October 8, 2014 ª2014 Elsevier Inc. 447
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T. cruzi-Infected Cells
PAR4(3)-, TSKb20-, or SIINFEKL-specific CD8+ T cells were generated by
dendritic cell (DC) vaccination as described previously (Padilla et al., 2009).
In short, C57Bl/6 mice were vaccinated with bone-marrow-derived DCs
loaded with PAR4(3), TSKb20, or SIINFEKL peptides and boosted 5 days later
with syngenic splenocytes loaded with the respective peptides. OVA specific
CD8+ T cells were generated by infection with Listeria monocytogenes ex-
pressing ova (Lm-ova), as described previously (Berg et al., 2003). Spleno-
cytes (106) collected 21 days post-DC vaccination or 14 days post-Lm-ova
infection were coincubated for 9–12 hr with 105 murine fibroblast (MC57G
fibrosarcoma cell line, ATCC) cells that have been infected for various lengths
of time with Tcwt; or with the corresponding peptide epitopes as positive con-
trols. For infecting MC57G cells, 106 T. cruzi trypomastigotes were added to
105 cells and washed off after 3 hr. At the end of coincubation with infected fi-
broblasts or the peptide epitopes, CD8+ CD44+ T cells were evaluated for
intracellular IFN-g, as described above.
Statistical Analysis
Data are presented as the mean ± SEM. Statistical analyses compared the
groups with a two-tailed Student’s t test. Only p values of less than or equal
to 0.05 were considered statistically significant.
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